Pharmacists and No Co-Pays Improves Diabetes A1C

In a project described in the March/April Journal of the American Pharmacists Association, employers in 10 U.S. cities agreed to waive copays for employees’ diabetes meds, and to fund regular meetings between pharmacists and diabetic employees. A year after the project launched, 914 patients who had been enrolled for at least three months ....MORE

First Consumer Test to Evaluate Diabetes Risk Coming Soon

The first  FDA approved consumer test to evaluate diabetes risk will be marketed exclusively in the United States by Glycemion, Inc. The BIOSAFE Diabetes Risk Assessment is a two-part process comprised of an immediate fasting glucose reading and a mail-in laboratory analysis for hemoglobin A1c, a blood glucose marker for the previous ninety-day period. More......